SB224 (2019) Detail

Relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.


CHAPTER 277

SB 224-FN - FINAL VERSION

 

03/07/2019   0590s

8May2019... 1673h

2019 SESSION

19-1020

01/10

 

SENATE BILL 224-FN

 

AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.

 

SPONSORS: Sen. Rosenwald, Dist 13; Sen. Fuller Clark, Dist 21; Sen. Hennessey, Dist 5; Sen. Chandley, Dist 11; Sen. Sherman, Dist 24; Rep. Nordgren, Graf. 12; Rep. Marsh, Carr. 8; Rep. Campion, Graf. 12; Rep. Cushing, Rock. 21; Rep. Berrien, Rock. 18

 

COMMITTEE: Commerce

 

─────────────────────────────────────────────────────────────────

 

AMENDED ANALYSIS

 

This bill clarifies insurance coverage for treatment for pediatric autoimmune neuropsychiatric disorders.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

03/07/2019   0590s

8May2019... 1673h 19-1020

01/10

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Nineteen

 

AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

277:1  Coverage for Certain Biologically-Based Mental Illnesses.  Amend RSA 417-E:1, II to read as follows:

II.  Notwithstanding any other provision of law, each insurer that issues or renews any policy of [group] accident or health insurance and each nonprofit health service corporation under RSA 420-A and health maintenance organization under RSA 420-B providing benefits for disease or sickness in the state of New Hampshire shall provide benefits for treatment and diagnosis of certain biologically-based mental illnesses under the same terms and conditions and which are no less extensive than coverage provided for any other type of health care for physical illness.

277:2  Coverage for Certain Biologically-Based Mental Illnesses.  Amend RSA 417-E:1, III(f) to read as follows:

(f)  Obsessive-compulsive disorder, including pediatric autoimmune neuropsychiatric disorders, when treatment, including the use of intravenous immunoglobulin therapy, is ordered by a physician.

277:3  Coverage for Certain Biologically-Based Mental Illnesses.  RSA 417-E:1, III(f) is repealed and reenacted to read as follows:

(f)  Obsessive-compulsive disorder, including pediatric autoimmune neuropsychiatric disorders.

277:4  Effective Date.  

I.  Section 3 of this act shall take effect July 1, 2024.

II.  The remainder of this act shall take effect 60 days after its passage.

 

Approved: July 19, 2019

Effective Date:

I. Section 3 shall take effect July 1, 2024.

II. Remainder shall take effect September 17, 2019.

 

 

Links


Date Body Type
Jan. 29, 2019 Senate Hearing
March 7, 2019 Senate Floor Vote
April 23, 2019 House Hearing
April 25, 2019 House Exec Session
House Floor Vote
May 8, 2019 House Floor Vote

Bill Text Revisions

SB224 Revision: 6625 Date: Dec. 4, 2019, 8:15 a.m.
SB224 Revision: 6279 Date: June 13, 2019, 1:36 p.m.
SB224 Revision: 5901 Date: June 4, 2019, 1:08 p.m.
SB224 Revision: 5463 Date: March 8, 2019, 12:40 p.m.
SB224 Revision: 5206 Date: Jan. 22, 2019, 4:27 p.m.

Docket


Sept. 17, 2019: II. Remainder Effective 09/17/2019


July 1, 2024: I. Section 3 Effective 07/01/2024


July 19, 2019: Signed by the Governor on 07/19/2019; Chapter 277


June 27, 2019: Enrolled (In recess 06/27/2019); SJ 21


June 27, 2019: Enrolled 06/27/2019 HJ 20 P. 53


June 13, 2019: Sen. Cavanaugh Moved to Concur with the House Amendment, MA, VV; 06/13/2019; SJ 20


May 8, 2019: Ought to Pass with Amendment 2019-1673h: MA VV 05/08/2019 HJ 15 P. 67


May 8, 2019: Amendment # 2019-1673h: AA VV 05/08/2019 HJ 15 P. 67


: Committee Report: Ought to Pass with Amendment # 2019-1673h (Vote 17-2; RC)


May 8, 2019: Committee Report: Ought to Pass with Amendment # 2019-1673h for 05/08/2019 (Vote 17-2; RC) HC 23 P. 14


April 25, 2019: Executive Session: 04/25/2019 01:30 pm LOB 302


April 25, 2019: Full Committee Work Session: 04/25/2019 09:30 am LOB 302


April 23, 2019: Public Hearing: 04/23/2019 01:30 pm LOB 302


March 20, 2019: Introduced 03/20/2019 and referred to Commerce and Consumer Affairs HJ 11 P. 71


March 7, 2019: Ought to Pass with Amendment 2019-0590s, MA, VV; OT3rdg; 03/07/2019; SJ 7


March 7, 2019: Committee Amendment # 2019-0590s, AA, VV; 03/07/2019; SJ 7


March 7, 2019: Committee Report: Ought to Pass with Amendment # 2019-0590s, 03/07/2019; SC 12


Jan. 29, 2019: Hearing: 01/29/2019, Room 103, SH, 02:00 pm; SC 8


Jan. 3, 2019: Introduced 01/03/2019 and Referred to Commerce; SJ 4